GlassScriptPhysician profile
Joseph A Binkiewicz
NPI 1891775029
$437.63
in general payments reported to CMS, 2019-2025
15 companies · $55.48 in 2025
The $55.48 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $44.58 · 2021: $47.18 · 2022: $31.71 · 2023: $90.56 · 2025: $55.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $100.20 | 2019-2023 | Lo Loestrin Fe |
| Minerva Surgical, INC | $62.31 | 2019-2023 | |
| Astellas Pharma US INC | $36.38 | 2023-2025 | Myrbetriq, Veozah |
| Roche Diagnostics Corporation | $34.70 | 2019 | |
| Pfizer INC. | $27.89 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $27.15 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.08 | 2020-2021 | |
| Agile Therapeutics, INC. | $22.15 | 2023 | Twirla |
| Organon LLC | $21.87 | 2025 | Nexplanon |
| Allergan, INC. | $16.66 | 2019 | |
| Hologic Sales and Service, LLC | $16.05 | 2025 | Aptima |
| Shield Therapeutics INC | $15.68 | 2023 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $12.34 | 2019 | |
| Boston Scientific Corporation | $11.35 | 2019 | |
| Meditrina | $6.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Binkiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.